ID: ALA4746132

Max Phase: Preclinical

Molecular Formula: C36H48O13

Molecular Weight: 688.77

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COC(COCCCCC1=C2C=CC3=CC=CC4=CC=C(C=C1)C2C34)CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O

Standard InChI:  InChI=1S/C36H48O13/c1-44-23(17-45-14-3-2-5-19-8-9-22-11-10-20-6-4-7-21-12-13-24(19)28(22)27(20)21)18-46-35-33(43)31(41)34(26(16-38)48-35)49-36-32(42)30(40)29(39)25(15-37)47-36/h4,6-13,23,25-43H,2-3,5,14-18H2,1H3/t23?,25-,26-,27?,28?,29+,30+,31-,32-,33-,34-,35-,36+/m1/s1

Standard InChI Key:  YAHLRCJLZCCDCT-YAQVSTSMSA-N

Associated Targets(Human)

MDA-MB-435 38290 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Small conductance calcium-activated potassium channel protein 3 210 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 688.77Molecular Weight (Monoisotopic): 688.3095AlogP: -0.14#Rotatable Bonds: 15
Polar Surface Area: 196.99Molecular Species: NEUTRALHBA: 13HBD: 7
#RO5 Violations: 3HBA (Lipinski): 13HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.94CX Basic pKa: CX LogP: 0.90CX LogD: 0.90
Aromatic Rings: 0Heavy Atoms: 49QED Weighted: 0.11Np Likeness Score: 1.57

References

1. Bauduin A,Papin M,Chantôme A,Couthon H,Deschamps L,Requejo-Isidro J,Vandier C,Jaffrès PA.  (2021)  Development of pyrene-based fluorescent ether lipid as inhibitor of SK3 ion channels.,  209  [PMID:33049604] [10.1016/j.ejmech.2020.112894]

Source